Syncom Formul.

{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "19.51",
    "chg": 0.18,
    "chgp": "0.93%",
    "dir": 1,
    "prev_price": "19.33",
    "mcapval": "1,763.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE312C01025",
    "curr_date": "Sep 11, 03:30 PM",
    "curr_time": "18:50 PM",
    "last_traded_at": "Sep 11, 03:30 PM IST",
    "bse_nse_vol": "1.02 cr",
    "exc_status": "Active",
    "traded_date": "Sep 11, 2026",
    "traded_date_str": "2026 09 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syncom-formul-831770-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Syncom Formulations (India) Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-hold-4188047",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_mojoScore_4188047.png",
        "date": "2026-09-09 10:10:04",
        "description": "Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Syncom Formulations Gains 5.65%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-gains-565-5-key-factors-driving-the-weeks-momentum-4183644",
        "imagepath": "",
        "date": "2026-09-05 15:04:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Technical rating upgraded to Hold, shares surge on bullish momentum</p>\n                    <p><strong>2 Sep:</strong> New 52-week high at Rs.20.89 amid sustained gains</p>\n                    <p><strong>3 Sep:</strong> Hits another 52-week high at Rs.22.18 with exceptional volume spike</p>\n                    <p><strong>3 Sep:</strong> Valuation shifts to very expensive, signalling heightened price attractiveness</p>\n                    <p><strong>4 Sep:</strong> Week closes at Rs.20.56, consolidating recent gains</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><..."
      },
      {
        "title": "Syncom Formulations Sees Exceptional Volume Surge Amidst Sustained Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-sees-exceptional-volume-surge-amidst-sustained-gains-4180782",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_most_active_equities_by_volume_4180782.png",
        "date": "2026-09-03 10:00:14",
        "description": "Syncom Formulations (India) Ltd has emerged as one of the most actively traded stocks by volume on 3 September 2026, registering a remarkable surge in investor participation and sustained price appreciation. The pharmaceutical company’s shares have demonstrated robust momentum, supported by a significant increase in traded volumes and a notable upgrade in its mojo grade, signalling a potential shift in market sentiment."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Syncom Formulations (India) Ltd to 52-Week High of Rs 22.18",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-hits-new-52-week-high-at-rs2218-4180750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_priceRelatedfactors_4180750.png",
        "date": "2026-09-03 09:54:23",
        "description": "With a sustained six-day rally culminating in a fresh 52-week high of Rs 22.18 on 3 Sep 2026, Syncom Formulations (India) Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market despite recent headwinds for the Sensex."
      },
      {
        "title": "Syncom Formulations Valuation Shifts Signal Heightened Price Attractiveness Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-valuation-shifts-signal-heightened-price-attractiveness-amid-sector-dynamics-4180214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_valuationdot_4180214.png",
        "date": "2026-09-03 08:01:13",
        "description": "Syncom Formulations (India) Ltd has witnessed a significant re-rating in its valuation metrics, moving from an expensive to a very expensive category. This shift comes alongside robust price appreciation and improved market sentiment, positioning the micro-cap pharmaceutical firm in a challenging valuation territory compared to its peers and historical averages."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Syncom Formulations (India) Ltd to 52-Week High of Rs 20.89",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-hits-new-52-week-high-at-rs2089-4179548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_priceRelatedfactors_4179548.png",
        "date": "2026-09-02 10:05:22",
        "description": "Syncom Formulations (India) Ltd has surged to a fresh 52-week high of Rs 20.89 on 2 Sep 2026, marking a significant milestone after a sustained rally that has delivered 22.08% returns over the past year, comfortably outperforming the Sensex’s decline of 4.71% during the same period."
      },
      {
        "title": "Syncom Formulations Shares Surge on Bullish Technical Momentum and Upgraded Rating",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-shares-surge-on-bullish-technical-momentum-and-upgraded-rating-4175371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SyncomFormulati_technicaldot_4175371.png",
        "date": "2026-08-31 08:02:09",
        "description": "Syncom Formulations (India) Ltd has witnessed a significant shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by strong price action, a 12.16% gain on the day, and a notable upgrade in its MarketsMOJO Mojo Grade from Sell to Hold, reflecting improving investor sentiment and technical strength in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Syncom Formulations Surges 20.57% in a Week: Key Drivers Behind the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-surges-2057-in-a-week-key-drivers-behind-the-rally-4174457",
        "imagepath": "",
        "date": "2026-08-29 15:03:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>24 Aug:</strong> Valuation shifts signal expensive territory amid mixed returns</p>\n                    <p><strong>27 Aug:</strong> Technical momentum shifts signal bullish outlook amid mixed indicators</p>\n                    <p><strong>28 Aug:</strong> New 52-week high reached at Rs.18.7</p>\n                    <p><strong>28 Aug:</strong> Exceptional volume surge accompanies positive momentum</p>\n                    <p><strong>28 Aug:</strong> Technical momentum shifts to mildly bullish trend</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.16.14</div><..."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-hold-4174235",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SyncomFormulati_mojoScore_4174235.png",
        "date": "2026-08-29 10:10:03",
        "description": "Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 August 2026, providing investors with the most up-to-date view of the company’s performance and prospects."
      }
    ],
    "total": 309,
    "sid": "831770",
    "stock_news_url": "https://www.marketsmojo.com/news/syncom-formulations-india-831770"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Sep-2026",
      "details": "Submission of copy of newpaper clippings of notice of 38th Annual General Meeting (AGM) Remote E-Voting Record Date and other details.",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "07-Sep-2026",
      "details": "Submission of 38th Annual Report along with the Notice of Annual General Meeting to be held on Wednesday 30th September 2026 through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) at 2:00 P.M. pursuant to Regulation 34(1) of SEBI (LODR) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
      "datetime": "07-Sep-2026",
      "details": "Submission of Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26 pursuant to regulation 34(2)(f) of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>10%</strong> dividend, ex-date: 23 Sep 26",
          "dt": "2026-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Syncom Formulations (India) Ltd is Rated Hold

2026-09-09 10:10:04

Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Syncom Formulations Gains 5.65%: 5 Key Factors Driving the Week’s Momentum

2026-09-05 15:04:14

Key Events This Week

31 Aug: Technical rating upgraded to Hold, shares surge on bullish momentum

2 Sep: New 52-week high at Rs.20.89 amid sustained gains

3 Sep: Hits another 52-week high at Rs.22.18 with exceptional volume spike

3 Sep: Valuation shifts to very expensive, signalling heightened price attractiveness

4 Sep: Week closes at Rs.20.56, consolidating recent gains

Week Open

<...

Read full news article

Syncom Formulations Sees Exceptional Volume Surge Amidst Sustained Gains

2026-09-03 10:00:14

Syncom Formulations (India) Ltd has emerged as one of the most actively traded stocks by volume on 3 September 2026, registering a remarkable surge in investor participation and sustained price appreciation. The pharmaceutical company’s shares have demonstrated robust momentum, supported by a significant increase in traded volumes and a notable upgrade in its mojo grade, signalling a potential shift in market sentiment.

Read full news article

Broad-Based Technical Strength Lifts Syncom Formulations (India) Ltd to 52-Week High of Rs 22.18

2026-09-03 09:54:23

With a sustained six-day rally culminating in a fresh 52-week high of Rs 22.18 on 3 Sep 2026, Syncom Formulations (India) Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market despite recent headwinds for the Sensex.

Read full news article

Syncom Formulations Valuation Shifts Signal Heightened Price Attractiveness Amid Sector Dynamics

2026-09-03 08:01:13

Syncom Formulations (India) Ltd has witnessed a significant re-rating in its valuation metrics, moving from an expensive to a very expensive category. This shift comes alongside robust price appreciation and improved market sentiment, positioning the micro-cap pharmaceutical firm in a challenging valuation territory compared to its peers and historical averages.

Read full news article

Broad-Based Technical Strength Lifts Syncom Formulations (India) Ltd to 52-Week High of Rs 20.89

2026-09-02 10:05:22

Syncom Formulations (India) Ltd has surged to a fresh 52-week high of Rs 20.89 on 2 Sep 2026, marking a significant milestone after a sustained rally that has delivered 22.08% returns over the past year, comfortably outperforming the Sensex’s decline of 4.71% during the same period.

Read full news article

Syncom Formulations Shares Surge on Bullish Technical Momentum and Upgraded Rating

2026-08-31 08:02:09

Syncom Formulations (India) Ltd has witnessed a significant shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by strong price action, a 12.16% gain on the day, and a notable upgrade in its MarketsMOJO Mojo Grade from Sell to Hold, reflecting improving investor sentiment and technical strength in the Pharmaceuticals & Biotechnology sector.

Read full news article

Syncom Formulations Surges 20.57% in a Week: Key Drivers Behind the Rally

2026-08-29 15:03:53

Key Events This Week

24 Aug: Valuation shifts signal expensive territory amid mixed returns

27 Aug: Technical momentum shifts signal bullish outlook amid mixed indicators

28 Aug: New 52-week high reached at Rs.18.7

28 Aug: Exceptional volume surge accompanies positive momentum

28 Aug: Technical momentum shifts to mildly bullish trend

Week Open

Rs.16.14

<...

Read full news article

Syncom Formulations (India) Ltd is Rated Hold

2026-08-29 10:10:03

Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 August 2026, providing investors with the most up-to-date view of the company’s performance and prospects.

Read full news article

View All News